Firefly Neuroscience (AIFF) Liabilities and Shareholders Equity (2010 - 2026)

Firefly Neuroscience's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $10.9 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 11.75% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $48.7 million (up 90.47% YoY), while the FY2025 annual figure was $10.5 million, up 127.71% from the prior year.
• Liabilities and Shareholders Equity was $10.9 million for Q1 2026 at Firefly Neuroscience, up from $10.5 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $21.2 million in Q1 2022 to a low of $2.6 million in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $9.7 million across 5 years, with a median of $8.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity plunged 69.02% in 2023, then surged 351.31% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $8.0 million in 2022, then slumped by 66.91% to $2.6 million in 2023, then soared by 74.21% to $4.6 million in 2024, then soared by 127.71% to $10.5 million in 2025, then grew by 4.13% to $10.9 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $10.9 million (Q1 2026), $10.5 million (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.